Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Nephroprotection Against Cisplatin in Head and Neck Cancer
NCT05640817Completed
- Sponsor
- Tanta University
- Start
- Jan 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of pentoxifylline in nephrotoxicity (2 arms), sponsored by Tanta University. Primary endpoint: Nephrotoxicity improvement as measured by CTCAE version 5.0 at 6 months. Started Jan 2023; status: completed.
02
Drugs
pentoxifylline
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on NCT05640817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05640817.